Our Opinion
Recently Viewed
Clear AllAs per SEBI's Riskometer.
Split between different types of investments
Split between categories of Equity investments
We have shifted from our proprietary CapRank classification system to SEBI’s market cap classification system with effect from 14 Jan, 2026.
|
Fund name
|
Rating |
Our Opinion |
Risk
|
Return (%) |
|
Expense Ratio (%)
|
|---|---|---|---|---|---|---|
|
UTI Healthcare Fund - Regular Plan
|
Very High
|
loading... |
2.27 |
|||
|
Very High
|
loading... |
1.86 |
||||
|
Very High
|
loading... |
1.93 |
||||
|
Very High
|
loading... |
1.81 |
||||
|
Very High
|
loading... |
1.94 |
₹1,107 Cr
1.00 (30)
5,000
--
500
6
About UTI Healthcare Fund - Regular Plan
UTI Healthcare Fund - Regular Plan is a equity mutual fund scheme of UTI Mutual Fund. Launched on June 28, 1999, it is currently managed by Kamal Gada. The fund has an expense ratio of 2.27% with an overall AUM (Assets Under Management) of ₹1,107 Cr.
UTI Healthcare Fund - Regular Plan is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies. The fund allows minimum lumpsum investment of ₹1,000 and minimum SIP of ₹500.
Investment Strategy
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Suitability
Nobody should invest in Pharma funds in our opinion, because:
If you still choose to invest:
Capital Gains Taxation
Disclaimer: The tax information has been prepared on a best-effort basis using information available in the public domain and other sources that Value Research considers reliable. This is not meant as tax advice, and we advise you to consult your tax advisor before making any decision. Value Research takes no responsibility and assumes no liability for any loss or damage arising from any investment or redemption decision based on this information.
Dividend Taxation
1 min read•By Value Research
1 min read•By Value Research
Subscribers of Value Research Fund Advisor can conveniently invest in the low-cost direct plan of UTI Healthcare Fund - Regular Plan through the Value Research Fund Advisor website.
Alternatively, mutual funds can also be purchased directly from the respective fund house’s website. For example, UTI Healthcare Fund - Regular Plan can be bought from the UTI Mutual Fund website. In such a case, if you are investing in multiple funds from different fund houses, you will need to transact separately on each fund house’s website.
The third option is to invest offline, by seeking assistance from a mutual fund distributor. Most banks also act as mutual fund distributors, and you can approach your bank for help in completing your investment.
The latest declared NAV of UTI Healthcare Fund - Regular Plan, is ₹278.1969 as of 19-Mar-2026.
| Company | Percentage of Portfolio |
|---|---|
|
9.42
|
|
|
7.04
|
|
|
5.79
|
|
|
4.25
|
|
|
3.75
|
Over the past five years, UTI Healthcare Fund - Regular Plan has delivered an annualised return of 15.89% as of 19-Mar-2026.
The minimum investment required to start investing in UTI Healthcare Fund - Regular Plan is ₹5,000 for the lump sum option and ₹500 for the SIP (Systematic Investment Plan) option.